Global Gene Delivery System Technology Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 101

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

According to our (Global Info Research) latest study, the global Gene Delivery System Technology Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Gene Delivery System Technology Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Gene Delivery System Technology Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Delivery System Technology Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Delivery System Technology Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Delivery System Technology Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Delivery System Technology Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Delivery System Technology Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Gene Delivery System Technology Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Market segment by Application
    Neurological Diseases
    Cancer
    Other

Market segment by players, this report covers
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Delivery System Technology Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Delivery System Technology Drug, with revenue, gross margin and global market share of Gene Delivery System Technology Drug from 2018 to 2023.
Chapter 3, the Gene Delivery System Technology Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Delivery System Technology Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Delivery System Technology Drug.
Chapter 13, to describe Gene Delivery System Technology Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Delivery System Technology Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Delivery System Technology Drug by Type
        1.3.1 Overview: Global Gene Delivery System Technology Drug Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Gene Delivery System Technology Drug Consumption Value Market Share by Type in 2022
        1.3.3 Viral Gene Delivery System
        1.3.4 Non-viral Gene Delivery System
    1.4 Global Gene Delivery System Technology Drug Market by Application
        1.4.1 Overview: Global Gene Delivery System Technology Drug Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Neurological Diseases
        1.4.3 Cancer
        1.4.4 Other
    1.5 Global Gene Delivery System Technology Drug Market Size & Forecast
    1.6 Global Gene Delivery System Technology Drug Market Size and Forecast by Region
        1.6.1 Global Gene Delivery System Technology Drug Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Gene Delivery System Technology Drug Market Size by Region, (2018-2029)
        1.6.3 North America Gene Delivery System Technology Drug Market Size and Prospect (2018-2029)
        1.6.4 Europe Gene Delivery System Technology Drug Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Gene Delivery System Technology Drug Market Size and Prospect (2018-2029)
        1.6.6 South America Gene Delivery System Technology Drug Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Gene Delivery System Technology Drug Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Delivery System Technology Drug Product and Solutions
        2.1.4 Biogen Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Delivery System Technology Drug Product and Solutions
        2.2.4 Novartis Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Gene Delivery System Technology Drug Product and Solutions
        2.3.4 Gilead Sciences Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Sarepta Therapeutics
        2.4.1 Sarepta Therapeutics Details
        2.4.2 Sarepta Therapeutics Major Business
        2.4.3 Sarepta Therapeutics Gene Delivery System Technology Drug Product and Solutions
        2.4.4 Sarepta Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.5 Alnylam Pharmaceuticals
        2.5.1 Alnylam Pharmaceuticals Details
        2.5.2 Alnylam Pharmaceuticals Major Business
        2.5.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product and Solutions
        2.5.4 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Gene Delivery System Technology Drug Product and Solutions
        2.6.4 Amgen Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Gene Delivery System Technology Drug Product and Solutions
        2.7.4 Spark Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Spark Therapeutics Recent Developments and Future Plans
    2.8 Akcea Therapeutics
        2.8.1 Akcea Therapeutics Details
        2.8.2 Akcea Therapeutics Major Business
        2.8.3 Akcea Therapeutics Gene Delivery System Technology Drug Product and Solutions
        2.8.4 Akcea Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Akcea Therapeutics Recent Developments and Future Plans
    2.9 bluebird bio
        2.9.1 bluebird bio Details
        2.9.2 bluebird bio Major Business
        2.9.3 bluebird bio Gene Delivery System Technology Drug Product and Solutions
        2.9.4 bluebird bio Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 bluebird bio Recent Developments and Future Plans
    2.10 Sunway Biotech
        2.10.1 Sunway Biotech Details
        2.10.2 Sunway Biotech Major Business
        2.10.3 Sunway Biotech Gene Delivery System Technology Drug Product and Solutions
        2.10.4 Sunway Biotech Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Gene Delivery System Technology Drug Product and Solutions
        2.11.4 SIBIONO Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Gene Delivery System Technology Drug Product and Solutions
        2.12.4 AnGes Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Gene Delivery System Technology Drug Product and Solutions
        2.13.4 Orchard Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans
    2.14 Human Stem Cells Institute
        2.14.1 Human Stem Cells Institute Details
        2.14.2 Human Stem Cells Institute Major Business
        2.14.3 Human Stem Cells Institute Gene Delivery System Technology Drug Product and Solutions
        2.14.4 Human Stem Cells Institute Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Delivery System Technology Drug Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Gene Delivery System Technology Drug by Company Revenue
        3.2.2 Top 3 Gene Delivery System Technology Drug Players Market Share in 2022
        3.2.3 Top 6 Gene Delivery System Technology Drug Players Market Share in 2022
    3.3 Gene Delivery System Technology Drug Market: Overall Company Footprint Analysis
        3.3.1 Gene Delivery System Technology Drug Market: Region Footprint
        3.3.2 Gene Delivery System Technology Drug Market: Company Product Type Footprint
        3.3.3 Gene Delivery System Technology Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Delivery System Technology Drug Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Gene Delivery System Technology Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2023)
    5.2 Global Gene Delivery System Technology Drug Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Gene Delivery System Technology Drug Consumption Value by Type (2018-2029)
    6.2 North America Gene Delivery System Technology Drug Consumption Value by Application (2018-2029)
    6.3 North America Gene Delivery System Technology Drug Market Size by Country
        6.3.1 North America Gene Delivery System Technology Drug Consumption Value by Country (2018-2029)
        6.3.2 United States Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        6.3.3 Canada Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        6.3.4 Mexico Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Gene Delivery System Technology Drug Consumption Value by Type (2018-2029)
    7.2 Europe Gene Delivery System Technology Drug Consumption Value by Application (2018-2029)
    7.3 Europe Gene Delivery System Technology Drug Market Size by Country
        7.3.1 Europe Gene Delivery System Technology Drug Consumption Value by Country (2018-2029)
        7.3.2 Germany Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        7.3.3 France Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        7.3.5 Russia Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        7.3.6 Italy Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region
        8.3.1 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2018-2029)
        8.3.2 China Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        8.3.3 Japan Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        8.3.4 South Korea Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        8.3.5 India Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        8.3.7 Australia Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Gene Delivery System Technology Drug Consumption Value by Type (2018-2029)
    9.2 South America Gene Delivery System Technology Drug Consumption Value by Application (2018-2029)
    9.3 South America Gene Delivery System Technology Drug Market Size by Country
        9.3.1 South America Gene Delivery System Technology Drug Consumption Value by Country (2018-2029)
        9.3.2 Brazil Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        9.3.3 Argentina Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country
        10.3.1 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2018-2029)
        10.3.2 Turkey Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)
        10.3.4 UAE Gene Delivery System Technology Drug Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Gene Delivery System Technology Drug Market Drivers
    11.2 Gene Delivery System Technology Drug Market Restraints
    11.3 Gene Delivery System Technology Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Gene Delivery System Technology Drug Industry Chain
    12.2 Gene Delivery System Technology Drug Upstream Analysis
    12.3 Gene Delivery System Technology Drug Midstream Analysis
    12.4 Gene Delivery System Technology Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Gene Delivery System Technology Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Gene Delivery System Technology Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Gene Delivery System Technology Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Gene Delivery System Technology Drug Product and Solutions
    Table 8. Biogen Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Delivery System Technology Drug Product and Solutions
    Table 13. Novartis Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 16. Gilead Sciences Major Business
    Table 17. Gilead Sciences Gene Delivery System Technology Drug Product and Solutions
    Table 18. Gilead Sciences Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Gilead Sciences Recent Developments and Future Plans
    Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 21. Sarepta Therapeutics Major Business
    Table 22. Sarepta Therapeutics Gene Delivery System Technology Drug Product and Solutions
    Table 23. Sarepta Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Sarepta Therapeutics Recent Developments and Future Plans
    Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Alnylam Pharmaceuticals Major Business
    Table 27. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product and Solutions
    Table 28. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Gene Delivery System Technology Drug Product and Solutions
    Table 33. Amgen Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. Spark Therapeutics Major Business
    Table 37. Spark Therapeutics Gene Delivery System Technology Drug Product and Solutions
    Table 38. Spark Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Spark Therapeutics Recent Developments and Future Plans
    Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
    Table 41. Akcea Therapeutics Major Business
    Table 42. Akcea Therapeutics Gene Delivery System Technology Drug Product and Solutions
    Table 43. Akcea Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Akcea Therapeutics Recent Developments and Future Plans
    Table 45. bluebird bio Company Information, Head Office, and Major Competitors
    Table 46. bluebird bio Major Business
    Table 47. bluebird bio Gene Delivery System Technology Drug Product and Solutions
    Table 48. bluebird bio Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. bluebird bio Recent Developments and Future Plans
    Table 50. Sunway Biotech Company Information, Head Office, and Major Competitors
    Table 51. Sunway Biotech Major Business
    Table 52. Sunway Biotech Gene Delivery System Technology Drug Product and Solutions
    Table 53. Sunway Biotech Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Sunway Biotech Recent Developments and Future Plans
    Table 55. SIBIONO Company Information, Head Office, and Major Competitors
    Table 56. SIBIONO Major Business
    Table 57. SIBIONO Gene Delivery System Technology Drug Product and Solutions
    Table 58. SIBIONO Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. SIBIONO Recent Developments and Future Plans
    Table 60. AnGes Company Information, Head Office, and Major Competitors
    Table 61. AnGes Major Business
    Table 62. AnGes Gene Delivery System Technology Drug Product and Solutions
    Table 63. AnGes Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. AnGes Recent Developments and Future Plans
    Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. Orchard Therapeutics Major Business
    Table 67. Orchard Therapeutics Gene Delivery System Technology Drug Product and Solutions
    Table 68. Orchard Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Orchard Therapeutics Recent Developments and Future Plans
    Table 70. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
    Table 71. Human Stem Cells Institute Major Business
    Table 72. Human Stem Cells Institute Gene Delivery System Technology Drug Product and Solutions
    Table 73. Human Stem Cells Institute Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Human Stem Cells Institute Recent Developments and Future Plans
    Table 75. Global Gene Delivery System Technology Drug Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Gene Delivery System Technology Drug Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Gene Delivery System Technology Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Gene Delivery System Technology Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Gene Delivery System Technology Drug Players
    Table 80. Gene Delivery System Technology Drug Market: Company Product Type Footprint
    Table 81. Gene Delivery System Technology Drug Market: Company Product Application Footprint
    Table 82. Gene Delivery System Technology Drug New Market Entrants and Barriers to Market Entry
    Table 83. Gene Delivery System Technology Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Gene Delivery System Technology Drug Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Gene Delivery System Technology Drug Consumption Value Share by Type (2018-2023)
    Table 86. Global Gene Delivery System Technology Drug Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Gene Delivery System Technology Drug Consumption Value by Application (2018-2023)
    Table 88. Global Gene Delivery System Technology Drug Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Gene Delivery System Technology Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Gene Delivery System Technology Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Gene Delivery System Technology Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Gene Delivery System Technology Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Gene Delivery System Technology Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Gene Delivery System Technology Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Gene Delivery System Technology Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Gene Delivery System Technology Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Gene Delivery System Technology Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Gene Delivery System Technology Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Gene Delivery System Technology Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Gene Delivery System Technology Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Gene Delivery System Technology Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Gene Delivery System Technology Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Gene Delivery System Technology Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Gene Delivery System Technology Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Gene Delivery System Technology Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Gene Delivery System Technology Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Gene Delivery System Technology Drug Raw Material
    Table 120. Key Suppliers of Gene Delivery System Technology Drug Raw Materials
List of Figures
    Figure 1. Gene Delivery System Technology Drug Picture
    Figure 2. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Gene Delivery System Technology Drug Consumption Value Market Share by Type in 2022
    Figure 4. Viral Gene Delivery System
    Figure 5. Non-viral Gene Delivery System
    Figure 6. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Gene Delivery System Technology Drug Consumption Value Market Share by Application in 2022
    Figure 8. Neurological Diseases Picture
    Figure 9. Cancer Picture
    Figure 10. Other Picture
    Figure 11. Global Gene Delivery System Technology Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Gene Delivery System Technology Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Gene Delivery System Technology Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Gene Delivery System Technology Drug Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Gene Delivery System Technology Drug Consumption Value Market Share by Region in 2022
    Figure 16. North America Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Gene Delivery System Technology Drug Revenue Share by Players in 2022
    Figure 22. Gene Delivery System Technology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Gene Delivery System Technology Drug Market Share in 2022
    Figure 24. Global Top 6 Players Gene Delivery System Technology Drug Market Share in 2022
    Figure 25. Global Gene Delivery System Technology Drug Consumption Value Share by Type (2018-2023)
    Figure 26. Global Gene Delivery System Technology Drug Market Share Forecast by Type (2024-2029)
    Figure 27. Global Gene Delivery System Technology Drug Consumption Value Share by Application (2018-2023)
    Figure 28. Global Gene Delivery System Technology Drug Market Share Forecast by Application (2024-2029)
    Figure 29. North America Gene Delivery System Technology Drug Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Gene Delivery System Technology Drug Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Gene Delivery System Technology Drug Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Gene Delivery System Technology Drug Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Gene Delivery System Technology Drug Consumption Value (2018-2029) & (USD Million)
    Figure 63. Gene Delivery System Technology Drug Market Drivers
    Figure 64. Gene Delivery System Technology Drug Market Restraints
    Figure 65. Gene Delivery System Technology Drug Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Gene Delivery System Technology Drug in 2022
    Figure 68. Manufacturing Process Analysis of Gene Delivery System Technology Drug
    Figure 69. Gene Delivery System Technology Drug Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Related Reports

Global Gene Delivery System Technology Drug Supply, Demand and Key Producers, 2023-2029

Global Gene Delivery System Technology Drug Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

The global Gene Delivery System Technology Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Gene Delivery System Technology Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gene Delivery System Technology Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gene Delivery System Technology Drug market size was valued at USD 9325.4 million in 2023 and is forecast to a readjusted size of USD 32040 million by 2030 with a CAGR of 19.3% during review period.

Global Gene Delivery System Technology Drug Supply, Demand and Key Producers, 2024-2030

Global Gene Delivery System Technology Drug Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Gene Delivery System Technology Drug market size is expected to reach $ 32040 million by 2030, rising at a market growth of 19.3% CAGR during the forecast period (2024-2030).

Product Tags

Gene Delivery System Technology Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>